Levothyroxine Sodium Tablet
Product Images NDC 68788-8793

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68788-8793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)
Chemical structure diagram of levothyroxine sodium, showing its molecular components including iodine-substituted aromatic rings, hydroxyl and amino groups, and sodium salt of the carboxylate with water of hydration.*
FDA Label Image

Levothyroxine Sodium Tablets Usp 0.175mcg 0.175mg (51ff81f2 92d7 4d05 92e4 04272f9447da 11)

Levothyroxine Sodium Tablets Usp 0.175mcg 0.175mg (51ff81f2 92d7 4d05 92e4 04272f9447da 11)
Levothyroxine Sodium Tablets 0.175 mg (175 mcg) oral tablets label by Preferred Pharmaceuticals Inc. The label highlights the dosage strength and generic name, notes generic for Synthroid, and includes storage and usage warnings. It also contains directions for use in English and Spanish, with placeholders for lot, batch, and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.